ModMed said on April 20 that it has acquired Bonsai Health, a healthcare technology company focused on AI-driven patient engagement, in a move aimed at expanding automation tools for specialty medical practices. The buyer framed the deal as part of its broader push to build what it calls an “AI-Powered Practice,” adding software designed to help providers reconnect with patients who are due for care and let them schedule visits with less staff involvement. The announcement was issued by ModMed and also appeared in syndicated release coverage, while publicly surfaced third-party reporting and deal analysis remained limited at the time of writing.
What the Acquisition Adds
At the center of the acquisition is Bonsai Health’s agentic AI platform, which is built to monitor patient histories, detect care gaps, identify open appointment capacity and trigger outreach through text and email. ModMed said those capabilities will strengthen its front-office automation stack by adding a more proactive layer of patient reactivation and self-scheduling to its existing engagement tools. In practical terms, the combined offering is positioned to help practices fill unused slots, reduce manual administrative work and improve follow-through on recommended care.
Why Bonsai Stood Out
Bonsai entered the market with a focused pitch around specialty care operations, particularly the challenge of finding patients who should return for treatment but have not yet booked appointments. That positioning gained visibility in late 2025, when the company announced a strategic partnership with the American Academy of Dermatology to bring its automation tools to dermatology practices, a sign that it had begun building traction in one of the specialty markets where ModMed already has a strong footprint. The fit is notable because ModMed serves specialists across dermatology, ophthalmology, orthopedics, gastroenterology and ENT, giving Bonsai’s workflow engine a larger installed base to target.
Leadership and Expansion Potential
ModMed said the deal also brings in Bonsai’s founders, Travis Schneider and Luke Kervin, whom it described as experienced operators in patient engagement and the former co-founders of PatientPop. Bonsai has separately highlighted that background in its own company materials, presenting itself as a startup built by healthcare software veterans with experience scaling provider-facing platforms. For ModMed, that matters because the acquisition is not only about product features, but also about adding leadership that has previously built and commercialized practice-growth technology in ambulatory care.
Competitive Context
The transaction lands at a time when healthcare software companies are increasingly racing to show that AI can move beyond documentation and clinical support into labor-intensive administrative workflows. In this case, the focus is not on replacing front-desk teams outright, but on automating repetitive outreach and scheduling tasks that can consume staff time and contribute to missed revenue opportunities when patients fall out of care. ModMed and its backer, Clearlake Capital, both used the announcement to argue that agentic AI is becoming a practical operating layer for specialty practices rather than a speculative add-on.
What It Could Mean for Providers
ModMed said it plans to scale Bonsai’s technology across its network of nearly 50,000 providers, suggesting the company sees immediate cross-sell potential rather than a distant integration roadmap. That reach could give Bonsai materially broader distribution, while also giving ModMed a stronger answer to competitors pitching AI-enabled scheduling, intake and patient communication tools to outpatient specialists. Even so, the real test will be execution, because providers tend to judge workflow software less by headline claims and more by whether it reliably reduces no-shows, fills schedules and lowers staff burden without adding complexity.
Taken together, the acquisition signals that healthcare IT vendors are treating patient engagement and front-office automation as a serious next phase for applied AI in medical practices. ModMed is betting that Bonsai’s care-gap detection and automated outreach tools can deepen its value proposition to specialists, while Bonsai gains access to a much larger provider base and the infrastructure of an established platform company. With limited external reporting available so far, the announcement remains largely defined by the companies’ own framing, but it still stands out as a notable consolidation move in the fast-growing market for AI-enabled practice operations.